C12Y 603/01002
Glutamate-ammonia ligase
Official title: Glutamate-ammonia ligase (6.3.1.2)
C12Y603/01002 (Glutamate-ammonia ligase) appears on 59 US grants and 113 published applications in this corpus.
Search patents in C12Y- Granted patents
- 59
- Published applications
- 113
- Assignees
- 56
- Inventors
- 253
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 1 | 4 |
| 2006 | 1 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 2 |
| 2012 | 1 | 1 |
| 2013 | 0 | 3 |
| 2014 | 1 | 2 |
| 2015 | 0 | 4 |
| 2016 | 5 | 5 |
| 2017 | 4 | 2 |
| 2018 | 2 | 10 |
| 2019 | 2 | 5 |
| 2020 | 5 | 5 |
| 2021 | 5 | 8 |
| 2022 | 4 | 14 |
| 2023 | 3 | 8 |
| 2024 | 4 | 9 |
| 2025 | 11 | 16 |
| 2026 | 9 | 7 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Hyaluronic acid-producing recombinant cells14 Jul 2026US 12,680,121 B2Givaudan SA
- Mammalian expression vectors30 Jun 2026US 12,668,809 B2Biocon Biologics Limited
- Phosphate sensing microbial gene switch9 Jun 2026US 12,649,699 B2Switch Bioworks, Inc.
- Guided microbial remodeling, a platform for the rational improvement of microbial species for agriculture28 Apr 2026US 12,612,639 B2Pivot Bio, Inc.
- Complement component 1s (C1s) deficient cells for production of vaccines and biopharmaceutical proteins24 Feb 2026US 12,559,526 B2The Regents of the University of California
- Bacterial glutamine synthetase as selection marker in mammalian cells24 Sep 2026US 2026/0286381 A1Boehringer Ingelheim International GmbH
- Generation of landing pad cell lines10 Sep 2026US 2026/0265781 A1Bristol-Myers Squibb Company
- Glutamine synthetase marker for recombinant expression6 Aug 2026US 2026/0226524 A1Shanghai ZhenGe Biotechnology Co., Ltd.
- Microorganism introduced with foreign glutamine synthetase and method of producing ltryptophan using the same30 Jul 2026US 2026/0218116 A1Cj Cheiljedang Corporation
- Methods and compositions for improving plant traits9 Jul 2026US 2026/0193150 A1Pivot Bio, Inc.
Most cited
By later US patents
- Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products88US 11,162,102 B2Dna Twopointo Inc. · 2021
- Methods and compositions for improving plant traits32US 9,975,817 B2Pivot Bio, Inc. · 2018
- Methods and compositions for improving plant traits30US 10,384,983 B2Pivot Bio, Inc. · 2019
- Methods and compositions for improving plant traits28US 10,556,839 B2Pivot Bio, Inc. · 2020
- Methods and compositions for improving plant traits25US 10,919,814 B2Pivot Bio, Inc. · 2021